Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oestrogen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01776008
What this trial is testing

Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeRecurrent Breast Carcinoma+5 more
National Cancer Institute (NCI) 16
Not applicableLooking for participantsNCT05283421
What this trial is testing

Improving Diagnostics in Cervical Dysplasia

Who this might be right for
Cervical Cancer
University of Aarhus 150
Very early researchEnded earlyNCT00651976
What this trial is testing

Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 213
Not applicableEnded earlyNCT05560685
What this trial is testing

SMART-ER: Symptom Monitoring With Patient-reported Outcomes

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 10
Testing effectiveness (Phase 2)Study completedNCT00871858
What this trial is testing

Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer

Who this might be right for
Breast Cancer
Institut Bergonié 120
Not applicableActive Not RecruitingNCT04597580
What this trial is testing

Personalised Disease Monitoring in Metastatic Breast Cancer

Who this might be right for
Breast Cancer MetastaticEstrogen Receptor-positive Breast Cancer
The Christie NHS Foundation Trust 97
Testing effectiveness (Phase 2)Study completedNCT00152282
What this trial is testing

Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women

Who this might be right for
AmenorrheaPostmenopause
Abbott 105
Testing effectiveness (Phase 2)Study completedNCT01160718
What this trial is testing

Fulvestrant With or Without AZD6244 in Treating Patients With Advanced Breast Cancer That Progressed After Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer
Swiss Cancer Institute 46
Not applicableUnknownNCT03768479
What this trial is testing

The Value of 18F-FES-PET/CT in Predicting Fulvestrant Efficacy in Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerFulvestrant
First Affiliated Hospital Xi'an Jiaotong University 68
Not applicableNot Yet RecruitingNCT07581288
What this trial is testing

Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression

Who this might be right for
Uterine BleedingUterine CancerUterine Neoplasms+5 more
University of British Columbia 50
Large-scale testing (Phase 3)Study completedNCT00238732
What this trial is testing

Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause

Who this might be right for
Vaginal Atrophy
Wyeth is now a wholly owned subsidiary of Pfizer 650
Post-approval studies (Phase 4)UnknownNCT04050592
What this trial is testing

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life

Who this might be right for
MenopauseAtherosclerosisCardiovascular Diseases+1 more
Hanna Savolainen-Peltonen 150
Testing effectiveness (Phase 2)Study completedNCT00365599
What this trial is testing

Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 43
Not applicableStudy completedNCT02927392
What this trial is testing

Brown Adipose Tissue Activity in Pre- and Postmenopausal Women

Who this might be right for
MenopauseObesity
University of Colorado, Denver 69
Very early researchStudy completedNCT01313039
What this trial is testing

Evaluation of the Use of AZD6244 to Induce Increased ER Expression and Anti-Estrogen Response in ER-Negative/Low Breast Cancer

Who this might be right for
Breast Cancer
University of Miami 4
Large-scale testing (Phase 3)Active Not RecruitingNCT05952557
What this trial is testing

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

Who this might be right for
Breast Cancer, Early Breast Cancer
AstraZeneca 5,511
Not applicableUnknownNCT03518528
What this trial is testing

Comparison of Vaginal and Transdermal Oestrogen Before Frozen Thawed Embryo Transfer

Who this might be right for
Embryo TransferInfertility
University Hospital, Angers 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06590857
What this trial is testing

Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

Who this might be right for
Metastatic Breast CancerHER2-negative Breast CancerER+ Breast Cancer+7 more
RayzeBio, Inc. 16
Early research (Phase 1)Ended earlyNCT03128619
What this trial is testing

Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeInvasive Breast Carcinoma+14 more
Jonsson Comprehensive Cancer Center 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05262400
What this trial is testing

Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

Who this might be right for
Breast CancerSolid Tumors
Pfizer 235
Next Page